🔎 Trials Near Me

Utama › Kanser Paru-paru Sel Kecil › Virginia › Arlington

Kajian klinikal Kanser Paru-paru Sel Kecil di Arlington, VA

23 kajian untuk Kanser Paru-paru Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Arlington (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Mengambil pesertaFasa 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi jauh
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • NEXT Virginia, Fairfax · 11 mi jauh
Umur 19 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06586957

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07365241

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Mengambil pesertaFasa 1/2
  • Inova Schar Cancer Institute Clinical Trials, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07488676

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Mengambil pesertaFasa 1
  • Virginia Cancer Specialists, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05983432

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

Mengambil pesertaFasa 1/2
  • NEXT Virginia, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07730021

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Site 1002, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07407933

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

Mengambil pesertaFasa 3
  • Virginia Cancer Specialists, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07625644

A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

Mengambil pesertaFasa 3
  • Virginia Cancer Specialists, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT07218146

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Mengambil pesertaFasa 1/2
  • Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi jauh
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07038343

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Mengambil pesertaFasa 3
  • Virginia Cancer Specialists, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06712355

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Mengambil pesertaFasa 1/2
  • Virginia Cancer Specialists, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06892548

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

Mengambil pesertaFasa 1
  • Next Virginia, Fairfax · 11 mi jauh
Umur 18 hingga 99 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT07531095

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

Mengambil pesertaFasa 2
  • Virginia Cancer Specialists Research Institute, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06095505

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Clinical Trial Site, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07749586

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Mengambil pesertaFasa 1/2
  • NEXT Virginia, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT05652686

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Mengambil pesertaFasa 1/2
  • NEXT Oncology Virginia, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jul 2026 · NCT07174583

A Study of LY4175408 in Participants With Advanced Cancer

Mengambil pesertaFasa 1
  • NEXT Virginia, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jun 2026 · NCT07046923

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

Mengambil pesertaFasa 1
  • NEXT Oncology Virginia, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jun 2026 · NCT07454642

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • NEXT Oncology Virginia, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Apr 2026 · NCT07424547

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • NEXT Virginia, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Feb 2026 · NCT07030257

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Research Site 102, Fairfax · 11 mi jauh
  • Research Site 112, Fairfax · 11 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Nov 2025 · NCT05914116

Kajian Kanser Paru-paru Sel Kecil di bandar lain

Kajian lain di Arlington

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.